Karuna Therapeutics Inc (DELISTED) (KRTX:DL)
329.83
0.00 (0.00%)
USD |
NASDAQ |
Mar 18, 16:00
Karuna Therapeutics Enterprise Value: 11.34B for March 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| March 18, 2024 | 11.34B |
| March 15, 2024 | 11.34B |
| March 14, 2024 | 11.33B |
| March 13, 2024 | 11.04B |
| March 12, 2024 | 11.05B |
| March 11, 2024 | 10.91B |
| March 08, 2024 | 10.94B |
| March 07, 2024 | 10.85B |
| March 06, 2024 | 10.88B |
| March 05, 2024 | 10.90B |
| March 04, 2024 | 10.88B |
| March 01, 2024 | 10.80B |
| February 29, 2024 | 10.71B |
| February 28, 2024 | 10.77B |
| February 27, 2024 | 10.75B |
| February 26, 2024 | 10.79B |
| February 23, 2024 | 10.95B |
| February 22, 2024 | 10.92B |
| February 21, 2024 | 10.90B |
| February 20, 2024 | 10.89B |
| February 16, 2024 | 10.88B |
| February 15, 2024 | 10.92B |
| February 14, 2024 | 10.97B |
| February 13, 2024 | 10.86B |
| February 12, 2024 | 10.88B |
| Date | Value |
|---|---|
| February 09, 2024 | 10.83B |
| February 08, 2024 | 10.79B |
| February 07, 2024 | 10.71B |
| February 06, 2024 | 10.77B |
| February 05, 2024 | 10.82B |
| February 02, 2024 | 10.74B |
| February 01, 2024 | 10.69B |
| January 31, 2024 | 10.68B |
| January 30, 2024 | 10.70B |
| January 29, 2024 | 10.70B |
| January 26, 2024 | 10.71B |
| January 25, 2024 | 10.70B |
| January 24, 2024 | 10.75B |
| January 23, 2024 | 10.78B |
| January 22, 2024 | 10.75B |
| January 19, 2024 | 10.77B |
| January 18, 2024 | 10.78B |
| January 17, 2024 | 10.79B |
| January 16, 2024 | 10.80B |
| January 12, 2024 | 10.80B |
| January 11, 2024 | 10.79B |
| January 10, 2024 | 10.82B |
| January 09, 2024 | 10.81B |
| January 08, 2024 | 10.80B |
| January 05, 2024 | 10.78B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
106.24M
Minimum
Oct 15 2019
11.34B
Maximum
Mar 15 2024
3.814B
Average
2.970B
Median
Dec 15 2021
Enterprise Value Benchmarks
| Bristol-Myers Squibb Co | 135.24B |
| RayzeBio inc (DELISTED) | 3.204B |
| Icosavax Inc (DELISTED) | 537.68M |
| Madrigal Pharmaceuticals Inc | 4.055B |
| Theseus Pharmaceuticals Inc (DELISTED) | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -113.82M |
| Total Expenses (Quarterly) | 129.59M |
| EPS Diluted (Quarterly) | -3.01 |
| Earnings Yield | -3.55% |
| Normalized Earnings Yield | -2.902 |